Psychedelic Therapies Become New Biotech Hotspot Amid New Legitimacy
For decades, psychedelic therapy was only an experimental idea under research by organizations at academic institutions including Johns Hopkins. This changed in 2018 after life sciences company COMPASS Pathways plc (NASDAQ:CMPS) received Breakthrough Therapy Designation ... [Read]
Compass Pathways Leads the Way as the First Psychedelics Company to IPO on the Nasdaq
September 24, 2020 (MicroSmallCap via Comtex) — Last year may have been all about cannabis, but it’s clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since Johnson & Johnson’s (NYSE:JNJ) ketamine-derived ... [Read]
MindMed Becomes First Public Psychedelic Pharmaceutical Company
Neuropharmaceutical company Mind Medicine (MindMed) Inc. (NEO: MMED) (OTC:MMEDF) made history Tuesday when it began trading on the NEO Exchange under the ticker MMED, making it the world’s first publicly traded psychedelic pharmaceutical company. “Today ... [Read]